7 deaths linked to malfunctioning glucose monitors
Digest more
Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors | A manufacturing defect on a single production line may have affected about 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.
The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a letter to distributors, health care providers and customers saying that some sensors need to be removed from where they are sold or used.
Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle Libre 3 sensors, after testing by the company found they ...
MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now available to Canadians living with diabetes. This innovative ...